GlassScriptPhysician profile
Nancy Ogden Beller
NPI 1598864423
$5,274.83
in general payments reported to CMS, 2019-2025
42 companies · $43.19 in 2025
The $43.19 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,091 · 2020: $1,309 · 2021: $1,443 · 2022: $91.14 · 2023: $203 · 2024: $94.28 · 2025: $43.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327 · Education: $13.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.93 |
| Education | $13.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $639.65 | 2019-2023 | Repatha, Otezla |
| Abbvie INC. | $627.49 | 2019-2025 | Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $489.68 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $404.03 | 2019-2023 | Cyltezo, Jardiance |
| Lilly USA, LLC | $385.58 | 2019-2023 | Taltz |
| Novo Nordisk INC | $384.82 | 2019-2023 | Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $251.15 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $151.42 | 2019 | |
| Radius Health, INC. | $149.55 | 2019-2021 | |
| Glaxosmithkline, LLC. | $148.61 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $137.08 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.26 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $122.46 | 2019-2020 | |
| Amarin Pharma, INC. | $112.30 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $112.19 | 2019-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Beller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.